Protocol for depression treatment utilizing H-coil deep brain stimulation

Yiftach Roth, Abraham Zangen

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


The Brainsway Deep TMS System for the treatment of major depressive disorder (MDD) was cleared by the FDA on January 2013 for the treatment of depressive episodes in adult patients suffering from MDD who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode, based on a large, prospective, double blind, randomized, controlled multicenter trial. This chapter presents the detailed protocol of this multicenter trial.

Original languageEnglish
Pages (from-to)313-336
Number of pages24
StatePublished - 1 Jan 2014


  • Deep transcranial magnetic stimulation
  • Major depression disorder
  • Multicenter trial

ASJC Scopus subject areas

  • Neuroscience (all)
  • Biochemistry, Genetics and Molecular Biology (all)
  • Pharmacology, Toxicology and Pharmaceutics (all)
  • Psychiatry and Mental health


Dive into the research topics of 'Protocol for depression treatment utilizing H-coil deep brain stimulation'. Together they form a unique fingerprint.

Cite this